Immune signatures of treatment response and immune-related adverse events in melanoma patients under checkpoint inhibitor therapy

被引：0
|
作者：
Reschke, R. [1 ]
Gussek, P. [1 ]
Boldt, A. [2 ]
Sack, U. [2 ]
Koehl, U. [2 ,3 ]
Lordick, F. [4 ,5 ]
Kreuz, M. [3 ]
Reiche, K. [3 ]
Simon, J. C. [1 ]
Ziemer, M. [1 ]
Kunz, M. [1 ]
机构：
[1] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04103 Leipzig, Germany
[2] Univ Leipzig, Inst Clin Immunol, D-04103 Leipzig, Germany
[3] Fraunhofer Inst Cell Therapy & Immunol, D-04103 Leipzig, Germany
[4] Univ Leipzig, Dept Oncol Gastroenterol Hepatol Pulmonol & Infec, D-04103 Leipzig, Germany
[5] Univ Canc Ctr Leipzig, D-04103 Leipzig, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P113
引用
收藏
页码：E57 / E57
页数：1
相关论文
共 50 条
  • [31] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
    Schneider, Bryan J.
    Naidoo, Jarushka
    Santomasso, Bianca D.
    Lacchetti, Christina
    Adkins, Sherry
    Anadkat, Milan
    Atkins, Michael B.
    Brassil, Kelly J.
    Caterino, Jeffrey M.
    Chau, Ian
    Davies, Marianne J.
    Ernstoff, Marc S.
    Fecher, Leslie
    Ghosh, Monalisa
    Jaiyesimi, Ishmael
    Mammen, Jennifer S.
    Naing, Aung
    Nastoupil, Loretta J.
    Phillips, Tanyanika
    Porter, Laura D.
    Reichner, Cristina A.
    Seigel, Carole
    Song, Jung-Min
    Spira, Alexander
    Suarez-Almazor, Maria
    Swami, Umang
    Thompson, John A.
    Vikas, Praveen
    Wang, Yinghong
    Weber, Jeffrey S.
    Funchain, Pauline
    Bollin, Kathryn
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (36) : 4073 - +
  • [32] Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
    Duraisamy, Prasanna
    Panicker, Vinitha Varghese
    Jose, Wesley Mannirathil
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2023, 13 (03):
  • [33] Associations between Immune-related Adverse Events and Prognosis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
    Inoue, Yusuke
    Inui, Naoki
    INTERNAL MEDICINE, 2024,
  • [34] Delayed immune-related adverse events in patients with advanced melanoma treated with immune checkpoint inhibitors
    Angeles, Arkhjamil
    Sonke, Eric
    Thao Phuong Nguyen
    Bahl, Gaurav
    Poon, Vincent Isaac
    Bernstein, Vanessa
    Weppler, Alison Margaret
    Savage, Kerry J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Abdel-Wahab, Noha
    Diab, Adi
    Yu, Robert K.
    Futreal, Andrew
    Criswell, Lindsey A.
    Tayar, Jean H.
    Dadu, Ramona
    Shannon, Vickie
    Shete, Sanjay S.
    Suarez-Almazor, Maria E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1939 - 1949
  • [36] Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors
    Noha Abdel-Wahab
    Adi Diab
    Robert K. Yu
    Andrew Futreal
    Lindsey A. Criswell
    Jean H. Tayar
    Ramona Dadu
    Vickie Shannon
    Sanjay S. Shete
    Maria E. Suarez-Almazor
    Cancer Immunology, Immunotherapy, 2021, 70 : 1939 - 1949
  • [37] Clinical Presentation of Immune-Related Endocrine Adverse Events during Immune Checkpoint Inhibitor Treatment
    Chieng, Jenny Hui Ling
    Htet, Zaw Win
    Zhao, Joseph J.
    Tai, E. Shyong
    Tay, Sen Hee
    Huang, Yiqing
    Wong, Alvin
    Yang, Samantha Peiling
    CANCERS, 2022, 14 (11)
  • [38] Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma
    Verheijden, Rik J.
    Burgers, Femke H.
    Janssen, Josephine C.
    Putkere, Anouk E.
    Veenstra, Sophie P. G. R.
    Hospers, Geke A. P.
    Aarts, Maureen J. B.
    Hehenkamp, Karel W.
    Doorneboschj, Veerle E.
    Verhaertk, Marthe
    van den Berkmortell, Franchette W. P. J.
    Chatzidionysiou, Katerina
    Llobell, Arturo
    Barros, Milton
    Maria, Alexandre T. J.
    Takeji, Akari
    Morillo, Jose-Salvador Garcia
    Lidars, Merav
    van Eijs, Mick J. M.
    Blank, Christian U.
    Aspeslagh, Sandrine
    Piersma, Djura
    Kapiteijn, Ellen
    Labots, Mariette
    Boers-Sonderen, Marye J.
    van der Veldt, Astrid A. M.
    Haanen, John B. A. G.
    May, Anne M.
    Suijkerbuijk, Karijn P. M.
    EUROPEAN JOURNAL OF CANCER, 2024, 207
  • [39] Factors Associated with Immune-Related Adverse Events in Immune Checkpoint Inhibitor Users
    Jung, Sun-Young
    Nam, Dal Ri
    Jung, Yu-Seon
    Lee, Jongmin
    Kim, Eunji
    DRUG SAFETY, 2024, 47 (12) : 1426 - 1426
  • [40] Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Middha, Pooja
    Thummalapalli, Rohit
    Quandt, Zoe
    Balaratnam, Karmugi
    Cardenas, Eduardo
    Falcon, Christina J.
    Margaret Lung Group, Princess
    Gubens, Matthew A.
    Huntsman, Scott
    Khan, Khaleeq
    Li, Min
    Lovly, Christine M.
    Patel, Devalben
    Zhan, Luna Jia
    Liu, Geoffrey
    Aldrich, Melinda C.
    Schoenfeld, Adam
    Ziv, Elad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
12345